Meridian Medical Products Ltd - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 07849992 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2019

FOR

MERIDIAN MEDICAL PRODUCTS LTD

Page

Company information

1

Statement of financial position

2

Notes to the financial statements

4

DIRECTOR:

Ms M T Vrina

SECRETARY:

KPM Consulting Ltd

REGISTERED OFFICE:

Langley House

Park Road

London

N2 8EY

REGISTERED NUMBER:

07849992 (England and Wales)

ACCOUNTANTS:

Accura Accountants Ltd

Langley House

Park Road

East Finchley

London

N2 8EY

FIXED ASSETS

Intangible assets

4

15,200

19,000

CURRENT ASSETS

Debtors

5

2,381,101

2,452,328

Cash at bank

7,344

7,770

2,388,445

2,460,098

CREDITORS

Amounts falling due within one year

6

1,830,802

1,832,283

NET CURRENT ASSETS

557,643

627,815

TOTAL ASSETS LESS CURRENT LIABILITIES

572,843

646,815

CREDITORS

Amounts falling due after more than one year

7

651,491

627,291

NET (LIABILITIES)/ASSETS

(78,648

)

19,524

CAPITAL AND RESERVES

Called up share capital

1,587

1,587

Retained earnings

(80,235

)

17,937

SHAREHOLDERS' FUNDS

(78,648

)

19,524

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 September 2020 and were signed by:

Ms M T Vrina - Director

1.	STATUTORY INFORMATION

Meridian Medical Products Ltd is a private company, limited by shares , registered in England and Wales. The

company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,

value added tax and other sales taxes.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost

less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Depreciation

Depreciation has been provided at the following rates in order to write off the assets over their estimated useful

lives.

Trade Marks and other intangibles Over 10 years

Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12

‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company

becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there

is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or

to realise the asset and settle the liability simultaneously.

Basic financial assets and liabilities

Basic financial assets, and liabilities are initially measured at transaction price including transaction costs and are

subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a

financing transaction, where the transaction is measured at the present value of the future receipts discounted at a

market rate of interest. Financial assets and liabilities classified as receivable or payable within one year are not

amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Trade

creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business

from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If

not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and

subsequently measured at amortised cost using the effective interest method.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual

arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of

the company after deducting all of its liabilities

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to

the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the

statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from

those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that

have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the

timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they

will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the

statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of

exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the

operating result.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2018 - NIL).

4.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

$

COST

At 1 January 2019

and 31 December 2019

38,000

AMORTISATION

At 1 January 2019

19,000

Charge for year

3,800

At 31 December 2019

22,800

NET BOOK VALUE

At 31 December 2019

15,200

At 31 December 2018

19,000

5.

DEBTORS

31.12.19

31.12.18

$

$

Amounts falling due within one year:

Trade debtors

1,565,481

1,573,691

Other debtors

1,081

1,081

1,566,562

1,574,772

Amounts falling due after more than one year:

Other debtors

814,539

877,556

Aggregate amounts

2,381,101

2,452,328

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.19

31.12.18

$

$

Trade creditors

1,830,136

1,830,135

Other creditors

666

2,148

1,830,802

1,832,283

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.12.19

31.12.18

$

$

Other creditors

651,491

627,291